GGrantIndex
← Search

Microscopy and Cell Analysis Shared Resource

$180,116P30FY2025CANIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications, trials & patents

Trial NCT06508463Trial NCT06387979Trial NCT06381154Trial NCT06353191Trial NCT06315595Trial NCT06271291Trial NCT06238648Trial NCT06207188Trial NCT06160206Trial NCT06115772Trial NCT06078709Trial NCT06075524Trial NCT06073951Trial NCT06058663Trial NCT05917145Trial NCT05910801Trial NCT05720624Trial NCT05717153Trial NCT05704283Trial NCT05703399Trial NCT05674123Trial NCT05653661Trial NCT05640765Trial NCT05612100Trial NCT05591092Trial NCT05584449Trial NCT05575440Trial NCT05560009Trial NCT05557877Trial NCT05556525Trial NCT05549661Trial NCT05547386Trial NCT05547347Trial NCT05541016Trial NCT05530759Trial NCT05526417Trial NCT05523154Trial NCT05518903Trial NCT05512767Trial NCT05507879Trial NCT05507541Trial NCT05497804Trial NCT05465954Trial NCT05465941Trial NCT05447923Trial NCT05447910Trial NCT05443971Trial NCT05438563Trial NCT05417867Trial NCT05416983Trial NCT05412953Trial NCT05411523Trial NCT05411497Trial NCT05410977Trial NCT05407038Trial NCT05407025Trial NCT05403580Trial NCT05399004Trial NCT05393713Trial NCT05392946Trial NCT05388877Trial NCT05388851Trial NCT05388058Trial NCT05388006Trial NCT05356897Trial NCT05294367Trial NCT05288062Trial NCT05269381Trial NCT05246670Trial NCT05232851Trial NCT05224271Trial NCT05222620Trial NCT05212428Trial NCT05199285Trial NCT05194293Trial NCT05176223Trial NCT05168163Trial NCT05130060Trial NCT05112627Trial NCT05112614Trial NCT05111314Trial NCT05077735Trial NCT05075980Trial NCT05053100Trial NCT05045066Trial NCT05033288Trial NCT05030298Trial NCT05018208Trial NCT05005182Trial NCT04999826Trial NCT04975516Trial NCT04967196Trial NCT04926948Trial NCT04925817Trial NCT04917744Trial NCT04906369Trial NCT04897009Trial NCT04895735Trial NCT04892277Trial NCT04892264

Abstract

MICROSCOPY AND CELL ANALYSIS SHARED RESOURCE: ABSTRACT The Microscopy and Cell Analysis Shared Resource (MCASR) offers state-of-the-art fluorescence-activated cell sorting (FACS) cytometry, optical and electron microscopy techniques, and advanced instrumentation, training, cyberinfrastructure, and expertise for cancer research. The MCASR facilitates the study and analysis of molecular, cellular, and tissue dynamics and three-dimensional architecture crucial for understanding cancer causation and treatment to meet its three Specific Aims: Aim 1: Provide training, access, support, and expertise enabling Mayo Clinic Comprehensive Cancer Center (MCCCC) members to use advanced imaging and FACS cytometry techniques in their research. Aim 2: Advise and assist MCCCC members in the design, planning, and execution of experimental studies using high-end imaging, cell sorting, and data analysis. Aim 3: Provide MCCCC members state-of-the-art microscopy and cell sorting instrumentation, expertise, and cyberinfrastructure to efficiently handle data storage, transfer, management, and analysis. The MCASR has extensive experience and is well equipped and staffed for advanced FACS and analysis, metabolic studies using the Seahorse Bioscience XF extracellular flux analyzer, and optical and electron microscopy imaging techniques, including super-resolution microscopy, multiphoton microscopy, confocal microscopy, total internal reflection fluorescence (TIRF), fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), standard transmission and scanning electron microscopy, and serial block-face scanning electron microscopy to provide three-dimensional images. About 40% of MCASR users are MCCCC members, who represent about 14% of overall revenue from charges. The MCASR has supported 53 publications by MCCCC members in the current funding period. Member Utilization 2019-2023: 182 Total (8 CPCS, 9 REDI, 48 CGSM, 45 CII, 39 NTTM, 33 ACTS) Publication by Members: 53, 24 with Impact Factor >10

View original record on NIH RePORTER →